INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 17 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q4 2015. The put-call ratio across all filers is 33.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 12 | -99.9% | 0.00% | – |
| Q3 2017 | $10,000 | -52.4% | 10,018 | +0.1% | 0.00% | – |
| Q2 2017 | $21,000 | -16.0% | 10,012 | 0.0% | 0.00% | – |
| Q1 2017 | $25,000 | +19.0% | 10,012 | 0.0% | 0.00% | – |
| Q3 2016 | $21,000 | +31.2% | 10,012 | 0.0% | 0.00% | – |
| Q2 2016 | $16,000 | -20.0% | 10,012 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | 0.0% | 10,012 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | +11.1% | 10,012 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -37.9% | 10,012 | 0.0% | 0.00% | – |
| Q2 2015 | $29,000 | – | 10,012 | +83333.3% | 0.00% | – |
| Q1 2015 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q1 2014 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST FOUNDATION ADVISORS | 98,600 | $202,000 | 0.02% |
| Atria Investments, Inc | 65,439 | $134,000 | 0.02% |
| Argent Trust Co | 15,121 | $31,000 | 0.02% |
| Stonehage Fleming Financial Services Holdings Ltd | 2,060 | $170,000 | 0.01% |
| Acrospire Investment Management LLC | 2,100 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 3,444 | $7,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,038 | $2,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,421 | $7,000 | 0.00% |
| 1832 Asset Management L.P. | 10,012 | $20,000 | 0.00% |